Trial intelligence / Profile preview

Ultrasound-guided pericapsular nerve group block in hip surgery (different ropivacaine concentrations and volumes)

ChiCTR2100052511Phase 4Completed

Sponsor
Hefei First People's Hospital
Start
Nov 2021
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of ropivacaine in hip fracture (3 arms), sponsored by Hefei First People's Hospital. Primary endpoint: Postoperative muscle strength at 6 hours. Started Nov 2021; status: completed.

02

Drugs

ropivacaine
03

Conditions

hip fracture

Beyond the preview

Go deeper on ChiCTR2100052511.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100052511.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call